Drug intelligence / Profile preview

closantel sodium

Development stage
Preclinical
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral, Subcutaneous, Intramuscular
01

Overview

Closantel sodium is a synthetic halogenated salicylanilide derivative used as a broad-spectrum anthelmintic in veterinary medicine. It is primarily indicated for the treatment and control of internal parasites in livestock, including the common liver fluke (*Fasciola hepatica*), blood-sucking gastrointestinal nematodes such as *Haemonchus contortus*, and larval stages of certain arthropods like the sheep nasal bot fly (*Oestrus ovis*). The drug's mechanism of action involves the uncoupling of mitochondrial oxidative phosphorylation in susceptible parasites, which disrupts ATP synthesis and leads to metabolic failure and death. Viyash Life Sciences is currently developing this small molecule in the preclinical stage for animal health applications.

Brand names
FlukiverSeponver
Other names
Sodium closantelClosantel sodium salt
02

Targets

CHIT1 (Chitotriosidase)SDH (Mitochondrial electron transport chain complex II)OXPHOS (Parasite mitochondrial oxidative phosphorylation system)Complex II (Succinate dehydrogenase)OXPHOS (Mitochondrial OXPHOS complexes)

Beyond the preview

Go deeper on closantel sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on closantel sodium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call